{"id":629,"date":"2023-12-29T11:02:55","date_gmt":"2023-12-29T09:02:55","guid":{"rendered":"https:\/\/webs.uab.cat\/gabrmn\/funding-and-research-projects\/"},"modified":"2026-04-02T19:19:56","modified_gmt":"2026-04-02T17:19:56","slug":"funding-and-research-projects","status":"publish","type":"page","link":"https:\/\/webs.uab.cat\/gabrmn\/en\/funding-and-research-projects\/","title":{"rendered":"Funding and research projects"},"content":{"rendered":"\n

Our group has funding from national and European competitive calls as well as collaborative or valorisation initiatives in the frame of CIBER or XARTEC. In a smaller proportion, we also hold agreements with private institutions. Below you will find a list of current and finished research projects\/initiatives.<\/p>\n\n\n\n

Current projects<\/h2>\n\n\n\n

Metabolomic Crossroads: Unraveling The Interplay Between Tumor Microenvironment And Metabolic Reprogramming. Impact In Glioma Therapy Response And MR-Based Follow-Up (TIMER-GLIO) <\/strong>.\nProyecto de Generaci\u00f3n de Conocimiento PID2023-147750NB-I00, 01\/09\/2024 – 31\/08\/2027. Ministerio de Ciencia e Innovaci\u00f3n. PI: Ana Paula Candiota<\/em>. Amount: 150.000\u20ac<\/p>\n\n\n\n

Targeted Elimination of HIV Reservoir and Senescent Cells Using Senolytic Nanoparticles (SENOVIR-NP). <\/strong>Projecte col\u00b7laboratiu CIBER-BBN \/ CIBERINFEC. 2026-2028. IP CIBERINFEC: Nuria Climent. IB CIBER-BBN: Julia Lorenzo. Import: 35.000\u20ac<\/p>\n\n\n\n

Grup de Recerca Consolidat de la Generalitat de Catalunya. N-TETRASCAN<\/a><\/strong> Grup de noves ter\u00e0pies pel tractament i seguiment no invasiu de malalties cerebrals i c\u00e0ncer <\/strong>(Ref: 2021 SGR 00135). IP: Julia Lorenzo<\/em>. <\/p>\n\n\n\n

European Federation for Cancer Images (EUCAIM<\/a>).<\/strong> European Commission, Grant Agreement number 1011100633, 2023-2026. A.P. Candiota and C. Ar\u00fas are members from partner CIBER. Coordinator: Peter Gordebeke<\/em>, European Institute for Biomedical Imaging Research (EIBIR), Austria. Scientific coordinator: Luis Mart\u00ed-Bonmat\u00ed, <\/em>Universidad de la Fe, Valencia. Amount: 17.789.829\u20ac (whole project, 76 partners), 112.906\u20ac (CIBER, affiliated partner).<\/p>\n\n\n\n

COST Action A COMPREHENSIVE NETWORK AGAINST BRAIN CANCER (Net4Brain)<\/strong>. Cost Action CA22103, 30\/10\/2023 – 29\/10\/2027. Rol: member of the Working Group 1: Noninvasive biomarker discorvery, and Working Group 2: preclinical modeling. Amount: variable, usually devoted to networking actions.<\/p>\n\n\n\n

Xarxa R+D+I en Tecnologies de la Salut (XarTEC SALUT<\/a>) 2021 XARDI 00008<\/strong>. 2025-2027. Ag\u00e8ncia de Gesti\u00f3 d\u2019Ajuts Universitaris i de Recerca (AGAUR). Role: Member of SINTTC group Grup de seguiment no invasiu i tractament dels tumors cerebrals<\/em>, from UAB, lead by Margarida Juli\u00e0. IP: Alexandre Perera Lluna (UPC).<\/em> Amount: 1.000.000\u20ac for the whole network.<\/p>\n\n\n\n

GABRMN_ Grupo CIBER-BBN_ CB06-01-0010<\/a><\/strong>. Instituto de Salud Carlos III. PI: Carles Ar\u00fas<\/em>. 01\/01\/2007 – present. Amount: variable according to group evaluation, with a minimum corresponding to a postdoctoral hiring. CIBER funding for 2023: 3.800.874 \u20ac.<\/p>\n\n\n\n

<\/p>\n\n\n\n

Finished projects<\/h2>\n\n\n\n

Diagnosis by molecular imaging: basic research and translational development (DIAMOND).<\/strong> Redes de Investigaci\u00f3n RED2022-134299-T, 01\/06\/2023-31\/05\/205. Partners<\/strong>: Instituto de Qu\u00edmica M\u00e9dica (IQM-CSIC), CIC BiomaGUNE, BIONAND, Vall d’Hebron Institut de Recerca, Universidad de Navarra, Hospital Gregorio Mara\u00f1on, Fundaci\u00f3n Jim\u00e9nez-Diaz, Universidad de Santiago de Compostela, Centro de Investigaci\u00f3n Energ\u00e9tica Medioambiental y Tecnolog\u00eda, Centro Nacional de Investigaciones Cardiovasculares Carlos III, Universitat Aut\u00f2noma de Barcelona<\/strong> (IP: Ana Paula Candiota<\/strong>)<\/em>, Institute for Instrumentation in Molecular Imaging, Centro de Investigaciones Biol\u00f3gicas CSIC, Instituto de Investigaciones Biom\u00e9dicas Alberto Sols, Instituto de Ciencia de Materiales de Madrid, Coordinador de la red: Fernando Herranz Rabanal (IQM-CSIC)<\/em>. Amount: 19.000\u20ac<\/p>\n\n\n\n

Mapping Intranasal Nanoconjugates for Parkinson: MRI Analysis of CNS Targeting and Biodistribution<\/strong>, MINN4PARK. CIBER BBN\/NED collaborative project. 01\/06\/2023 \u2013 30\/06\/2025 . PI BBN: Ana Paula Candiota<\/em>, PI NED: Marta Mart\u00ednez Vicente. Amount: 35.000\u20ac<\/p>\n\n\n\n

Xarxa R+D+I en Tecnologies de la Salut (XarTEC SALUT<\/a>) 2021 XARDI 00021<\/strong>. 2023-2025. Ag\u00e8ncia de Gesti\u00f3 d\u2019Ajuts Universitaris i de Recerca (AGAUR). Role: Member of SINTTC group Grup de seguiment no invasiu i tractament dels tumors cerebrals<\/em>, from UAB, lead by Margarida Juli\u00e0. IP: Alexandre Perera Lluna (UPC).<\/em> Amount: 1.000.000\u20ac for the whole network.<\/p>\n\n\n\n

Conveni Marc de Col\u00b7laboraci\u00f3 pel desenvolupament d\u2019activitats d\u2019investigaci\u00f3. <\/strong>Universitat Aut\u00f2noma de Barcelona and Institut d’Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed, 2023-2025. PIs UAB: Julia Lorenzo y Ana Paula Candiota, PI Parc Taul\u00ed: Silvia Gil<\/em>. Amount: 5.030\u20ac<\/p>\n\n\n\n

Leveling up in GB therapy monitoring: towards a universal biomarker of immune system attack (TRIBUTE<\/a>).<\/strong> Proyecto de Generaci\u00f3n de Conocimiento PID2020-113058GB-I00, 01\/01\/2021 – 30\/06\/2024. Ministerio de Ciencia e Innovaci\u00f3n. PI: Ana Paula Candiota<\/em>. Amount: 121.000\u20ac<\/p>\n\n\n\n

Radical Dendrimers as New Metal-frEE Contrast Agents for Glioblastoma Diagnosis, Radical-NEED<\/strong>. CIBER-BBN Research Valorisation Project Radical. 22\/03\/2023 \u2013 22\/03\/2024 . PI: Vega Lloveras<\/em>. Amount: 20.000\u20ac<\/p>\n\n\n\n

COST Action GLIMR Glioma MR Imaging 2.0<\/a>.<\/strong> COST Action CA18206, 12\/09\/2019 – 11\/03\/2024. Role: Working Group 1 member. Advanced MRI biomarkers for glioma characterization. Amount: variable, usually devoted to networking actions.<\/p>\n\n\n\n

INtegrating Magnetic Resonance SPectroscopy and Multimodal Imaging for Research and Education in MEDicine (INSPiRE-MED<\/a>).<\/strong> European Commission Marie Sk\u0142odowska-Curie Actions. Grant Agreement 813120, 01\/01\/2019-30\/06\/2023. Role: partner CIBER member. IP: Dominique Sapey-Marinier<\/em>. Amount: 3.946.345 (whole project), 205.904\u20ac (partner CIBER).<\/p>\n\n\n\n

Multiparametric MR approaches for non-invasive Glioblastoma therapy response follow-up (MAGRes<\/a>).<\/strong> European Commission, Grant Agreement 777222 (Third Party), 20\/05\/2019 – 30\/10\/2020. PI: Ana Paula Candiota (partner CIBER)<\/em>. Amount: 100.000\u20ac.<\/p>\n\n\n\n

COST Action Nano2Clinic<\/a>. Cancer Nanomedicine – from the bench to the bedside.<\/strong> COST Action CA17140, 2018-2023. Role: member of Working Group 3: Preclinical studies of nanodrugs<\/p>\n\n\n\n

Noninvasive MR-based ImagiNg of Immune system action during glIoblastomA TreatmEnt MR-INITIATE<\/a><\/strong>. CIBER-BBN Research Valorisation Project. CIBER-BBN, 29\/03\/2021 \u2013 29\/03\/2022. PI: Ana Paula Candiota. Amount: 20.000\u20ac<\/p>\n\n\n\n

Nosological Imaging as a Tool for Adjusting therapy combination to improve glioma management: preclinical studies<\/strong> (NOTAGLI<\/a>, reference CIB16-BI001), 07\/2017- 06\/2018. Intramural project CIBER-BBN, Partners: 4 CIBER groups, 1 clinical grup and 3 external groups, one of them international. PI: Ana Paula Candiota.<\/em> Amount: basal CIBER groups.<\/p>\n\n\n\n

E-learning platform for Medical Informatics to improve Vocational and ICT Skills (E-MEDIVIP<\/a>).<\/strong> European Union Erasmus +. Cooperation for innovation and the exchange of good practices (KA2). A.P. Candiota was a member of the partner CIBER-BBN. PI: Emre Dandil<\/em>. PI partner CIBER-BBN: Margarida Juli\u00e0-Sap\u00e9. Amount: 228.899\u20ac (whole project), 38.127\u20ac (partner CIBER-BBN).<\/p>\n\n\n\n

Imagen Molecular de glioma de alto grado para la mejora de la respuesta al tratamiento (MOLIMAGLIO<\/a>).<\/strong> Ministerio de Economia y Competitividad, SAF2014-52332-R, 01\/01\/2015 – 31\/12\/2017. Role. Participant. PI: Carles Ar\u00fas<\/em>. Amount: 242.000\u20ac.<\/p>\n\n\n\n

Grup de Recerca Consolidat de la Generalitat de Catalunya. GABRMN Grup d\u2019Aplicacions Biom\u00e8diques de la RMN<\/strong> (Ref: 2014 SGR 0191), 2014-2016. Role. Participant. PI: Carles Ar\u00fas.<\/em><\/p>\n\n\n\n

Mejora de los protocolos para diagn\u00f3stico y seguimiento de respuesta a terapia en tumores cerebrales mediante estrategias de Imagen Molecular basadas en Resonancia Magn\u00e9tica (MARESCAN<\/a>).<\/strong> Ministerio de Ciencia e Innovaci\u00f3n, SAF2011-23870, 01\/01\/2012-31\/12\/2014. Role. Participant. PI: Carles Ar\u00fas<\/em>. Amount: 326.700\u20ac.<\/p>\n\n\n\n

Influencia de la citicolina en la neuroreparaci\u00f3n despu\u00e9s de un infarto cerebral. <\/strong>Universitat Aut\u00f2noma de Barcelona and Fundaci\u00f3 Institut de Recerca del Hospital de la Santa Creu i Sant Pau. PI UAB: Carles Ar\u00fas. PI Sant Pau: Joan Mart\u00ed F\u00e0bregas<\/em>. Amount: 84.464\u20ac.<\/p>\n\n\n\n

Imagen molecular y de fenotipo de la progresi\u00f3n tumoral cerebral en modelos murinos. Extensi\u00f3n translacional a humanos (PHENOIMA<\/a>).<\/strong> Ministerio de Ciencia e Innovaci\u00f3n, SAF2008-03323, 01\/01\/2009-31\/12\/2011. Role: Participant. PI: Carles Ar\u00fas<\/em>. Amount: 269.830\u20ac.<\/p>\n\n\n\n

Desarrollo de estrategias de imagen molecular y de fenotipo, in vivo de modelos murinos de tumores gliales y de enfermedad de Alzheimer (IMAFEN).<\/strong> Intramural project CIBER-BBN, 2008-2009. Partners: 12 CIBER groups. Scientific coordination: A.P.Candiota. PI: Carles Ar\u00fas. <\/em>Amount: 538.727\u20ac<\/p>\n\n\n\n

Agent-based Distributed Decision Support System for Brain Tumour Diagnosis and Prognosis (HEALTHAGENTS<\/a>).<\/strong> European Commission, IST-2004-27214, 1\/1\/2006-31\/12\/2008. Role. Member of partner UAB. PI: Mag\u00ed Lluch Ariet. PI Partner UAB: Carles Ar\u00fas.<\/em> Amount: 3.791.269\u20ac (whole project), 494.272\u20ac (partner UAB)<\/p>\n\n\n\n

Grup de Recerca Consolidat de la Generalitat de Catalunya. Grup d’Aplicacions Biom\u00e8diques de l’Espectrosc\u00f2pia de Resson\u00e0ncia Magn\u00e8tica Nuclear de Catalunya (GABERC) <\/strong>(Ref: 2005 SGR 0863), 2005-2009. Role. Participant. PI: Carles Ar\u00fas. <\/em>Amount: 26.600\u20ac<\/p>\n\n\n\n

e-Tumour<\/a>, web accessible MR decision support system for brain tumour diagnosis and prognosis, incorporating in vivo and ex vivo genomic and metabolomic data.<\/strong> European Commission, FP6-2002-LIFESCIHEALTH 503094, 01\/02\/2004 – 31\/7\/2009. Role. Member of partner UAB. PI: Bernardo Celda. PI Partner UAB: Carles Ar\u00fas<\/em>. Amount: 7.499.382\u20ac (whole project), 1.077.999\u20ac (Partner UAB).<\/p>\n\n\n\n

Mejora del diagn\u00f3stico y de la valoraci\u00f3n pron\u00f3stica de tumores cerebrales humanos in vivo. Modelos animales y celulares para la metabol\u00f3mica de la progresi\u00f3n tumoral. Fase 2 (MEDIVO2<\/a>).<\/strong> Ministerio de Educaci\u00f3n y Ciencia, SAF2005-03650, 01\/01\/2005-31\/12\/2008. Role: Participant. PI: Carles Ar\u00fas.<\/em> Amount:178.500\u20ac.<\/p>\n\n\n\n

Aplicaciones biom\u00e9dicas de la resonancia Magn\u00e9tica Nuclear. <\/strong>Ag\u00e8ncia de Gesti\u00f3 d’Ajuts Universitaris i de Recerca, 2004XT-00051, 2004-2006. Amount: 6.000\u20ac.<\/p>\n\n\n\n

Business agents,<\/strong> PROFIT FIT-150500-2003-491<\/a>. 01\/01\/2003-31\/12\/2003. Ministerio de Ciencia y Tecnolog\u00eda. PI: Carles Ar\u00fas. Amount: 24.370\u20ac<\/p>\n\n\n\n

Red internacional para el reconocimiento de patrones en tumores mediante Resonancia Magn\u00e9tica (Acci\u00f3n Especial). <\/strong>Ministerio de Ciencia y Tecnolog\u00eda, SAF2002-10280-E, 23\/04\/2003-31\/12\/2003. PI: Carles Ar\u00fas.<\/em> Amount: 34.272\u20ac.<\/p>\n\n\n\n

Mejora del diagn\u00f3stico y de la valoraci\u00f3n pron\u00f3stica de tumores cerebrales humanos “in vivo” y en modelos animales y celulares de la patolog\u00eda (MEDIVO<\/a>).<\/strong> Ministerio de Ciencia y Tecnolog\u00eda, SAF2002-00440, 01\/01\/2002-31\/12\/2004. Role: Participant. PI: Carles Ar\u00fas. Amount:169.500\u20ac.<\/p>\n\n\n\n

Red tem\u00e1tica de Aplicaciones Biom\u00e9dicas de la Resonancia Magn\u00e9tica Nuclear. <\/strong>Ag\u00e8ncia de Gesti\u00f3 d’Ajuts Universitaris i de Recerca, 2002XT-00048, 2002-2004. IP: Carles Ar\u00fas<\/em>. Amount: 6.750\u20ac.<\/p>\n\n\n\n

Grup de Recerca Consolidat de la Generalitat de Catalunya. GABRMN Grup d\u2019Aplicacions Biom\u00e8diques de la RMN<\/strong> (Ref: 2001 SGR 00194), 2001-2005. Role. Participant. PI: Carles Ar\u00fas<\/em>. Amount: 22.237\u20ac<\/p>\n\n\n\n

INTERPRET<\/a>: international network for pattern recognition of tumours using magnetic resonance<\/strong>. European Commission, IST-1999-10310, 01\/01\/2000-31\/12\/2002. Role: Participant. PI: Carles A\u00fas<\/em>. Amount: 2.200.000\u20ac.<\/p>\n\n\n\n

Red tem\u00e1tica de Aplicaciones Biom\u00e9dicas de la Resonancia Magn\u00e9tica Nuclear. <\/strong>Ag\u00e8ncia de Gesti\u00f3 d’Ajuts Universitaris i de Recerca, 2000XT-00043, 2000-2002. PI: Carles Ar\u00fas<\/em>. Amount: 4.808\u20ac.<\/p>\n\n\n\n

Grupo de Aplicaciones Biom\u00e9dicas de la Espectroscopia de Resonancia Magn\u00e9tica Nuclear (GABERC)<\/strong> (Ref: 1999SGR-00328), 1999-2001. PI: Carles Ar\u00fas<\/em>. Amount: 17.429\u20ac<\/p>\n\n\n\n

Aplicaciones cl\u00ednicas de la espectroscop\u00eda de resonancia magn\u00e9tica nuclear: 1. Desarrollo de un sistema experto para la diagnosis, prognosis y seguimiento de la respuesta a la terapia en tumores cerebrales humanos. 2. Mecanismo bioqu\u00edmico y utilidad cl\u00ednica de la suplementaci\u00f3n dietaria con creatina<\/strong>, ref. SAF99-0101<\/a>, 01\/06\/1999-31\/05\/2002. Comisi\u00f3n Interministerial de Ciencia y Tecnolog\u00eda CICYT, PI: Carles Ar\u00fas<\/em>. Amount: 67.613\u20ac<\/p>\n\n\n\n

Aplicaciones biom\u00e9dicas de la Resonancia Magn\u00e9tica Nuclear<\/strong>, 1998XT-00010. 01\/01\/1998 – 31\/12\/1999. PI: Carles Ar\u00fas<\/em>. Amount: 4.507\u20ac<\/p>\n\n\n\n

Triglic\u00e9ridos como marcadores de hipoxia y de necrosis en tumores cerebrales. Detecci\u00f3n in vivo por espectroscopia de RMN<\/strong>, HF1997-0232<\/a>. 01\/01\/1998-31\/12\/1999. Direcci\u00f3n General de Ense\u00f1anza Superior e Investigaci\u00f3n Cient\u00edfica, PI: Carles Ar\u00fas<\/em>. Amount: 3.876\u20ac<\/p>\n\n\n\n

An\u00e1lisis mediante reconocimiento de patrones, in vitro e in vivo, de espectros
de RMN de tumores cerebrales humanos. Aplicaciones diagn\u00f3sticas<\/strong>, HB1997-0139<\/a>. 01\/01\/1998-31\/12\/1999. Direcci\u00f3n General de Ense\u00f1anza Superior e Investigaci\u00f3n Cient\u00edfica, PI: Carles Ar\u00fas<\/em>. Amount: 7.753\u20ac<\/p>\n\n\n\n

Desenvolupament i consolidaci\u00f3 de xarxes tem\u00e0tiques: Grup multidisplinari
per l’estudi de c\u00e0ncer de mama<\/strong>, 1996XT-00043, 01\/01\/997 – 31\/12\/1999. Generalitat de Catalunya, PI: Carles Ar\u00fas<\/em>. Amount: 7.813\u20ac<\/p>\n\n\n\n

Desarrollo de las Aplicaciones Cl\u00ednicas de la Espectroscopia de Resonancia
Magn\u00e9tica Nuclear (MRS) como T\u00e9cnica no-Invasiva para el Estudio de la Patolog\u00eda Tumoral Cerebral y la Fisiolog\u00eda Muscular<\/strong>, SAF96-0147. 26\/4\/1996-25\/4\/1999. Comisi\u00f3n Interministerial de Ciencia y Tecnolog\u00eda (CICYT). PI: Carles Ar\u00fas<\/em>. Amount: 60.101\u20ac<\/p>\n\n\n\n

Pattern recognition and neural network processing of in vivo and in vitro 1H
NMR spectra of human brain tumors for diagnostic applications<\/strong>, HB1995-0258. 01\/04\/1995 – 31\/12\/1997. PI: Carles Ar\u00fas. Amount: 2.914\u20ac<\/p>\n\n\n\n

Desarrollo de protocolos de inter\u00e9s diagn\u00f3stico mediante espectroscop\u00eda
resonancia magn\u00e9tica nuclear. Aplicaci\u00f3n en el estudio del metabolismo de tejidos excitables y b\u00fasqueda de marcadores tumorales<\/strong>, SAF93-0582-C02-01. 18\/05\/1993 – 17\/05\/1996. Comisi\u00f3n Interministerial de Ciencia y Tecnolog\u00eda (CICYT), PI: Carles Ar\u00fas. Amount: 54.091\u20ac.<\/p>\n\n\n\n

Obtenci\u00f3n de patrones metab\u00f3licos tisulares mediante espectroscopia
bidimensional de resonancia magn\u00e9tica nuclear (RMN-2D)<\/strong>, PB89-0282. 02\/08\/1990 – 01\/08\/1993. Direcci\u00f3n General de Investigaci\u00f3n Cient\u00edfica y T\u00e9cnica (DGICYT). PI: Carles Ar\u00fas. Amount: 45.075\u20ac<\/p>\n","protected":false},"excerpt":{"rendered":"

Our group has funding from national and European competitive calls as well as collaborative or valorisation initiatives in the frame of CIBER or XARTEC. In a smaller proportion, we also hold agreements with private institutions. Below you will find a list of current and finished research projects\/initiatives. Current projects Metabolomic Crossroads: Unraveling The Interplay Between […]<\/p>\n","protected":false},"author":2658,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-629","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/webs.uab.cat\/gabrmn\/en\/wp-json\/wp\/v2\/pages\/629","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/webs.uab.cat\/gabrmn\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/webs.uab.cat\/gabrmn\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/webs.uab.cat\/gabrmn\/en\/wp-json\/wp\/v2\/users\/2658"}],"replies":[{"embeddable":true,"href":"https:\/\/webs.uab.cat\/gabrmn\/en\/wp-json\/wp\/v2\/comments?post=629"}],"version-history":[{"count":8,"href":"https:\/\/webs.uab.cat\/gabrmn\/en\/wp-json\/wp\/v2\/pages\/629\/revisions"}],"predecessor-version":[{"id":1105,"href":"https:\/\/webs.uab.cat\/gabrmn\/en\/wp-json\/wp\/v2\/pages\/629\/revisions\/1105"}],"wp:attachment":[{"href":"https:\/\/webs.uab.cat\/gabrmn\/en\/wp-json\/wp\/v2\/media?parent=629"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}